Adnan Sami

Adnan Sami

Auto-generated profile, based on publicly available information

Adnan Sami

University of the Punjab Quaid-i-Azam Campus: University of the Punjab

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
ASAdnan Sami
Adnan Sami
MHMuhammad Zeshan Haider
Muhammad Zeshan Haider
MSMuhammad Shafiq
Muhammad Shafiq
SSSaleh Sadiq
Saleh Sadiq
FAFarooq Ahmad
Farooq Ahmad
Carotenoid cleavage oxygenases (CCOs) enzymes play an important role in plant growth and development by producing a wide array of apocarotenoids and their derivatives. These compounds are vital for colouring flowers and fruits and synthesizing plant hormones such as abscisic acid and strigolactones. Despite their importance, the gene family responsible for CCOs in sunflowers has not been studied. In this study, we identify the CCO genes of the sunflower plant to fill this knowledge gap. Phylogenetic and synteny analysis indicated that the Helianthus annnus CCO (HaCCO) proteins are conserved in different plant species and they can be divided into three subgroups based on their conserved domains. MEME analysis and multiple sequence alignment showed that conserved motifs exist in the sequence of HaCCO genes. Cis-regulatory elements (CREs) analysis of the HaCCO genes revealed the presence of multiple plant hormones and abiotic and biotic responsive elements in their promoters, suggesting that these genes might be responsive to plant hormones, developmental and drought stress, which could be utilized to develop more resilient crops. Genes belonging to the 9-cis-epoxy carotenoid dioxygenases (NCED) subgroups predominantly exhibit chloroplast localization, whereas the genes found in other groups are primarily localized in the cytoplasm. These 21 identified HaCCOs were regulated by 60 miRNAs indicating the crucial role of microRNAs in gene regulation in sunflowers. Gene expression analysis under drought stress revealed significant up-regulation of HaNCED16 and HaNCED19 genes that provide pivotal role in ABA hormone biosynthesis. While during organ-specific gene expression analysis HaCCD12 and HaCCD20 genes exhibit higher activity in leaves, indicating a potential role in leaf pigmentation. These studies provide a foundation for future research on the regulation and functions of this gene family. It could potentially be utilized to develop molecular markers that could be used in breeding programs to develop new sunflower lines.

20 June 2006 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
SASyeda Hoorulain Ahmed
Syeda Hoorulain Ahmed
RSR. K. Shahid
R. K. Shahid
ASA. Sami
A. Sami
SYS. Yadav
S. Yadav
IAImad Ahmad
Imad Ahmad
KHK. Haider
K. Haider
6091 Background: Gemcitabine is an antimetabolite agent that has demonstrated activity in various solid and hematological malignancies. Although thrombocytopenia is a known side effect, gemcitabine-related thrombocytosis has been uncommonly reported. Chemotherapy increases the risk of thrombo-embolism in patients with cancer. The study aimed to identify the incidence of gemcitabine-related thrombocytosis and to determine whether it has been associated with an increased risk of thrombo-embolism. Methods: Medical records of 175 consecutive adults patients with a malignant disease who received gemcitabine at Saskatoon Cancer Center were reviewed. Patients with history of prior thrombo-embolism or with baseline thrombocytosis were excluded. Fisher’s Exact test was done for statistical analysis. Results: 149 eligible patients with median age of 62 (26–83) and M:F of 1.01:1 were identified. 141 (95%) patients had advanced malignancy and 61 (41%) had received prior chemotherapy. 106 (71%) patients received combination of chemotherapy and 95% of those patients received gemcitabine in combination with a platinum compound. Median number of cycle was 3 (1–8). Median platelets count prior to commencement of gemcitabine was 285 × 109 (44–449). 83 (56%) patients experienced thrombocytopenia whereas 69 (46%) patients experienced thrombocytosis within 3 weeks of treatment with gemcitabine. Median post-gemcitabine platelet count in patients with thrombocytosis was 622 × 109 (457–1385). 15 (10%) patients experienced thrombocytosis with each cycle of gemcitabine. Median duration of thrombocytosis was 2 weeks (0.5−5). 13 (9%) of 149 patients experienced a vascular event (venous, n=9; arterial, n=4) within 6 weeks of treatment with gemcitabine. Median platelet count prior to the vascular event was 268 × 109 (79–669). All except one patient had advanced malignancy and 85% had received combination of chemotherapy. 5 of 69 (7%) patients with thrombocytosis experienced a vascular event compared with 8 of 80 (10%) patients without thrombocytosis (p=0.77). Conclusions: Gemcitabine has been associated with an increased incidence of thrombocytosis. However gemcitabine-related thrombocytosis is a transient phenomenon and has not been associated with an increased risk of a vascular event. No significant financial relationships to disclose.